Perioperative allogenenic blood transfusion is associated with worse clinical outcomes for hepatocellular carcinoma: a meta-analysis.
BACKGROUND AND OBJECTIVE: The impact of perioperative allogenenic blood transfusion (ABT) on clinical outcomes for hepatocellular carcinoma (HCC) is conflicting and unclear. The aim of this meta-analysis is to evaluate the association between ABT and HCC clinical outcomes. Outcomes evaluated were al...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3669337?pdf=render |
_version_ | 1828756957313368064 |
---|---|
author | Lei Liu Zhiwei Wang Songqi Jiang Bingfeng Shao Jibing Liu Suqing Zhang Yilong Zhou Yuan Zhou Yixin Zhang |
author_facet | Lei Liu Zhiwei Wang Songqi Jiang Bingfeng Shao Jibing Liu Suqing Zhang Yilong Zhou Yuan Zhou Yixin Zhang |
author_sort | Lei Liu |
collection | DOAJ |
description | BACKGROUND AND OBJECTIVE: The impact of perioperative allogenenic blood transfusion (ABT) on clinical outcomes for hepatocellular carcinoma (HCC) is conflicting and unclear. The aim of this meta-analysis is to evaluate the association between ABT and HCC clinical outcomes. Outcomes evaluated were all-cause death, tumor recurrence and postoperative complications. METHODS: Relevant articles were identified through MEDLINE search (up to November 2012). Meta-analyses were performed by using the fixed or random effect models. Study heterogeneity was assessed by Q-test and I(2) test. Publication bias was evaluated by funnel plots, Egger's and Begg's test. RESULTS: A total of 5635 cases from 22 studies finally met our inclusion criteria. Meta-analysis indicated HCC patients with ABT had an increased risk of all-cause death at 3 and 5 years after surgery (respectively: OR = 1.92, 95% CI, 1.61-2.29,P<0.001; OR = 1.60, 95% CI, 1.47-1.73,P<0.001 ) compared with those without ABT. The risk of tumor recurrence was significantly higher for ABT cases at 1, 3 and 5 years (respectively: OR = 1.70, 95% CI, 1.38-2.10, P<0.001; OR = 1.22, 95% CI, 1.08-1.38, P<0.001; OR = 1.16, 95% CI, 1.08-1.24, P<0.001). The HCC cases with ABT significantly increased postoperative complications occurrence compared with non-ABT cases (OR = 1.78,95% CI, 1.34-2.37, P<0.001). CONCLUSIONS: The findings from the current meta-analysis demonstrated that ABT was associated with adverse clinical outcomes for HCC patients undergoing surgery, including increased death, recurrence and complications. Therefore, ABT should not be performed if possible. |
first_indexed | 2024-12-10T23:25:23Z |
format | Article |
id | doaj.art-b7f0164118ff483bae0613c7a9577031 |
institution | Directory Open Access Journal |
issn | 1932-6203 |
language | English |
last_indexed | 2024-12-10T23:25:23Z |
publishDate | 2013-01-01 |
publisher | Public Library of Science (PLoS) |
record_format | Article |
series | PLoS ONE |
spelling | doaj.art-b7f0164118ff483bae0613c7a95770312022-12-22T01:29:36ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0185e6426110.1371/journal.pone.0064261Perioperative allogenenic blood transfusion is associated with worse clinical outcomes for hepatocellular carcinoma: a meta-analysis.Lei LiuZhiwei WangSongqi JiangBingfeng ShaoJibing LiuSuqing ZhangYilong ZhouYuan ZhouYixin ZhangBACKGROUND AND OBJECTIVE: The impact of perioperative allogenenic blood transfusion (ABT) on clinical outcomes for hepatocellular carcinoma (HCC) is conflicting and unclear. The aim of this meta-analysis is to evaluate the association between ABT and HCC clinical outcomes. Outcomes evaluated were all-cause death, tumor recurrence and postoperative complications. METHODS: Relevant articles were identified through MEDLINE search (up to November 2012). Meta-analyses were performed by using the fixed or random effect models. Study heterogeneity was assessed by Q-test and I(2) test. Publication bias was evaluated by funnel plots, Egger's and Begg's test. RESULTS: A total of 5635 cases from 22 studies finally met our inclusion criteria. Meta-analysis indicated HCC patients with ABT had an increased risk of all-cause death at 3 and 5 years after surgery (respectively: OR = 1.92, 95% CI, 1.61-2.29,P<0.001; OR = 1.60, 95% CI, 1.47-1.73,P<0.001 ) compared with those without ABT. The risk of tumor recurrence was significantly higher for ABT cases at 1, 3 and 5 years (respectively: OR = 1.70, 95% CI, 1.38-2.10, P<0.001; OR = 1.22, 95% CI, 1.08-1.38, P<0.001; OR = 1.16, 95% CI, 1.08-1.24, P<0.001). The HCC cases with ABT significantly increased postoperative complications occurrence compared with non-ABT cases (OR = 1.78,95% CI, 1.34-2.37, P<0.001). CONCLUSIONS: The findings from the current meta-analysis demonstrated that ABT was associated with adverse clinical outcomes for HCC patients undergoing surgery, including increased death, recurrence and complications. Therefore, ABT should not be performed if possible.http://europepmc.org/articles/PMC3669337?pdf=render |
spellingShingle | Lei Liu Zhiwei Wang Songqi Jiang Bingfeng Shao Jibing Liu Suqing Zhang Yilong Zhou Yuan Zhou Yixin Zhang Perioperative allogenenic blood transfusion is associated with worse clinical outcomes for hepatocellular carcinoma: a meta-analysis. PLoS ONE |
title | Perioperative allogenenic blood transfusion is associated with worse clinical outcomes for hepatocellular carcinoma: a meta-analysis. |
title_full | Perioperative allogenenic blood transfusion is associated with worse clinical outcomes for hepatocellular carcinoma: a meta-analysis. |
title_fullStr | Perioperative allogenenic blood transfusion is associated with worse clinical outcomes for hepatocellular carcinoma: a meta-analysis. |
title_full_unstemmed | Perioperative allogenenic blood transfusion is associated with worse clinical outcomes for hepatocellular carcinoma: a meta-analysis. |
title_short | Perioperative allogenenic blood transfusion is associated with worse clinical outcomes for hepatocellular carcinoma: a meta-analysis. |
title_sort | perioperative allogenenic blood transfusion is associated with worse clinical outcomes for hepatocellular carcinoma a meta analysis |
url | http://europepmc.org/articles/PMC3669337?pdf=render |
work_keys_str_mv | AT leiliu perioperativeallogenenicbloodtransfusionisassociatedwithworseclinicaloutcomesforhepatocellularcarcinomaametaanalysis AT zhiweiwang perioperativeallogenenicbloodtransfusionisassociatedwithworseclinicaloutcomesforhepatocellularcarcinomaametaanalysis AT songqijiang perioperativeallogenenicbloodtransfusionisassociatedwithworseclinicaloutcomesforhepatocellularcarcinomaametaanalysis AT bingfengshao perioperativeallogenenicbloodtransfusionisassociatedwithworseclinicaloutcomesforhepatocellularcarcinomaametaanalysis AT jibingliu perioperativeallogenenicbloodtransfusionisassociatedwithworseclinicaloutcomesforhepatocellularcarcinomaametaanalysis AT suqingzhang perioperativeallogenenicbloodtransfusionisassociatedwithworseclinicaloutcomesforhepatocellularcarcinomaametaanalysis AT yilongzhou perioperativeallogenenicbloodtransfusionisassociatedwithworseclinicaloutcomesforhepatocellularcarcinomaametaanalysis AT yuanzhou perioperativeallogenenicbloodtransfusionisassociatedwithworseclinicaloutcomesforhepatocellularcarcinomaametaanalysis AT yixinzhang perioperativeallogenenicbloodtransfusionisassociatedwithworseclinicaloutcomesforhepatocellularcarcinomaametaanalysis |